Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

97.93 +0.97 (+1.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stocks Pause As Traders Await Jobs Data, Nvidia Falls On Antitrust Investigation, Crude Rises To $75: What's Driving Markets Thursday?
Wall Street experienced a relatively quiet day on Thursday, with major indices trading within tight ranges as investors remain cautious ahead of the highly anticipated May jobs report, set for release... 
Via Benzinga
J.M. SmuckerPosts Upbeat Earnings, Joins Toro Company, United Natural Foods, Semtech And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Is It Time to Buy May's Worst-Performing S&P 500 Stocks?
These were the S&P 500's biggest losers in May. But could they be winners over the long run? 
Via The Motley Fool
Topics Stocks
Beyond The Numbers: 7 Analysts Discuss Illumina Stock
Via Benzinga
Peering Into Illumina's Recent Short Interest
Via Benzinga
Illumina Unusual Options Activity For May 07
Via Benzinga
7 Large-Cap Stocks That Can Jump 50% By 2025
It isn't easy to find large-cap stocks offering 50% upside but that's exactly what this list provides for investors. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today. 
Via InvestorPlace
Beyond The Numbers: 6 Analysts Discuss Illumina Stock
Via Benzinga
Wall Street Looks To Feed Off Apple's Post-Earnings Power But Key Jobs Data May Upset The Cart: Analyst Says 'A Lot Of These Clouds Will Lift' If This Happens
Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evident ahead of the all-important non-farm payrolls report. 
Via Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. 
Via Benzinga
Topics Stocks
ILMN Stock Earnings: Illumina Beats EPS, Beats Revenue for Q1 2024
ILMN stock results show that Illumina beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
U.S. stocks look to push ahead on a positive path, now that the Federal Reserve’s rate decision is in the rearview mirror. Major index futures point to a positive open on Thursday. 
Via Benzinga
Topics Stocks
Looking Into Illumina's Recent Short Interest
Via Benzinga
Leading the Way: Swoop Named Provider of Choice for Employee Shuttling by Fortune 500 & Renowned Technology Companies
LOS ANGELES - March 20, 2024 - PRLog -- Swoop Inc. the leading group transportation service provider, is proud to announce its recent success in providing best-in-class employee shuttling services to... 
Via PRLog
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion. 
Via InvestorPlace
Jim Cramer Rejects Illumina As 'It's Not Well-Run,' Recommends Buying This Tech Stock 'Right Here, Right Now'
Jim Cramer doesn't recommend buying Dynatrace stock due to its high price. Canopy Growth is the best pot stock. BrightSpring, Illumina, and Bank of America also mentioned. Cramer recommends buying Palo... 
Via Benzinga
Topics Cannabis
The Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving
Investing with the Ark Invest guru is a roller coaster ride, but she always keeps her big ideas for the future in front of her. 
Via InvestorPlace
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER). 
Via Benzinga
Nasdaq’s Nosebleed Section: 3 Expensive Stocks to Sell Before It’s Too Late
Investors might want to be wary and dump these expensive Nasdaq stocks to sell before their impending and potentially violent corrections. 
Via InvestorPlace
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months
Over the past 12 months, 10 Large-Cap stocks have underperformed all others. 
Via Talk Markets
Why Illumina Stock Zoomed Higher on Thursday
The company's chances for winning an important legal battle have improved dramatically. 
Via The Motley Fool
EU Antitrust Regulators Overstepped in Illumina-Grail Deal, Says Court Adviser
EU antitrust advisor criticizes decision blocking Illumina's $7.1 billion bid for Grail, citing overreach. Impact on Qualcomm deal scrutinized. Commission's jurisdiction challenged amid legal battles.... 
Via Benzinga
Icahn’s All-In: 3 Stocks Billionaire Carl Icahn Is Betting Big On
Carl Icahn, the corporate raider turned activist investor, has put most of his master limited partnership' portfolio into just three stocks. 
Via InvestorPlace
Gene Sequencing Firm Illumina Escapes Carl Icahn's Second Proxy Battle Amid Grail Divestment Efforts
Carl Icahn halts new challenge to Illumina's board, sparing the gene sequencing giant a second proxy battle. Focus shifts to legal action over Grail acquisition. 
Via Benzinga
Earnings Crushers: Unveiling Q4’s 3 Top Stock Superstars
Although there were many earnings winners in the fourth quarter, these three picks have more promise than their counterparts. 
Via InvestorPlace
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth. 
Via InvestorPlace
7 No-Frills Dividend Stocks for Your Must-Own List
Income investors don't need to invest in risky businesses when no-frills dividend stocks get the job done just fine. 
Via InvestorPlace
Over $1M Bet On This Industrial Stock? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Monday, there were a few notable insider trades. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback